Press release
Multiple System Atrophy Market Size was approximately USD 125 million in 2022
The Multiple System Atrophy market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM Multiple System Atrophy market size from 2019 to 2032. The report also covers current Multiple System Atrophy treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential.
Key takeaways from the Multiple System Atrophy Market Research Report
• As per DelveInsight analysis, the multiple system atrophy market size in the 7MM was approximately USD 125 million in 2021.
• In 2022, the market size of MSA was highest in the US among the 7MM, accounting for approximately USD 84 million, which is further expected to increase by 2032.
• The leading Multiple System Atrophy Market Companies include H Lundbeck A/S, Theravance Biopharma, Brain Neurotherapy Bio, Inc., Jonis Pharmaceuticals, Inc., Alterity Therapeutics, and others.
• Promising Multiple System Atrophy Pipeline Therapies include Lu AF82422, Ampreloxetine (TD-9855), AAV2-GDNF Gene Therapy, ION464, ATH434, and others.
For more insights into the Multiple System Atrophy Market Landscape, visit Multiple System Atrophy Market Therapeutics Landscape @ https://www.delveinsight.com/sample-request/multiple-system-atrophy-msa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Multiple System Atrophy Overview
Multiple system atrophy (MSA) is a rare, rapidly progressing, fatal neurodegenerative disorder of uncertain etiology that is clinically characterized by a variable combination of Parkinsonism, cerebellar impairment, and autonomic and motor dysfunctions. Depending on the predominant clinical phenotype, the disease is sub-classified into a parkinsonian variant (MSA-P) associated with SND, a cerebellar (MSA-C) variant with OPCA with predominant cerebellar features, and a combination of both forms referred to as "mixed" MSA.
Multiple System Atrophy Epidemiology Segmentation in the 7MM
• Multiple System Atrophy Diagnosed Prevalent Cases
• Multiple System Atrophy Gender-specific Diagnosed Prevalent Cases
• Multiple System Atrophy Age-specific Diagnosed Prevalent Cases
• Multiple System Atrophy Type-specific Diagnosed Prevalent Cases
To know more information of the Multiple System Atrophy Epidemiology Segmentation of the report, click here for Multiple System Atrophy Epidemiology Insights @ https://www.delveinsight.com/sample-request/multiple-system-atrophy-msa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Multiple System Atrophy Emerging Drugs
• Ampreloxetine (TD-9855): Theravance Biopharma
Ampreloxetine is an investigational, once-daily Norepinephrine Reuptake Inhibitor (NRI) in development for treating patients with symptomatic neurogenic orthostatic hypotension (nOH). It has a high affinity for binding to norepinephrine transporters. By blocking the action of these transporters, ampreloxetine causes an increase in extracellular concentrations of norepinephrine.
Multiple System Atrophy Market Outlook
Currently, no disease-modifying agent is approved. The drug used to treat PD (parkinsonism), most notably levodopa (SINEMET), is also prescribed for MSA individuals. However, the efficacy of such medications varies greatly among affected individuals. Apart from levodopa, other drugs used to treat PD may be used to treat MSA individuals. These include dopamine agonists such as ropinirole (Requip) and pramipexole (Mirapexin), which increase the activity of dopamine receptors in the brain. This helps the brain receive dopamine signals. Midodrine hydrochloride (ProAmatine) has been used to treat low blood pressure, sometimes associated with MSA. Adrenergic drugs such as ephedrine may be used to treat low blood pressure. L-threo-dihydroxyphenylserine (L-DOPS or L-threo-DOPS) can also treat low blood pressure.
Multiple System Atrophy Treatment Market
The approved multiple system atrophy market segment includes NORTHERA (droxidopa), the world's first approved therapy for symptomatic nOH. Dainippon Sumitomo Pharma (DSP) developed it and commercialized it in Japan in 1989. DSP sold the drug license to Chelsea Therapeutics International in 2006. Chelsea received accelerated approval for NORTHERA from the US FDA in February 2014 for symptomatic benefit in adult patients with nOH, and exclusivity will expire in February 2021. nOH is found in approximately 66-90% of MSA patients and is a major cause of disability and injury in the disease.
Browse More Related Reports of the Multiple System Atrophy Market Research Reports, click here for Multiple System Atrophy Market Forecast @ https://www.delveinsight.com/sample-request/multiple-system-atrophy-msa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Multiple System Atrophy Market Research Report
• Coverage- 7MM
• Multiple System Atrophy Companies- H Lundbeck A/S, Theravance Biopharma, Brain Neurotherapy Bio, Inc., Jonis Pharmaceuticals, Inc., Alterity Therapeutics, and others.
• Multiple System Atrophy Pipeline Therapies- Lu AF82422, Ampreloxetine (TD-9855), AAV2-GDNF Gene Therapy, ION464, ATH434, and others.
• Multiple System Atrophy Market Dynamics: Multiple System Atrophy Market Drivers and Barriers
Read the Full Research Report of the Multiple System Atrophy Market Forecast Report, click here for Multiple System Atrophy Market Drivers and Barriers @ https://www.delveinsight.com/sample-request/multiple-system-atrophy-msa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Multiple System Atrophy Market Overview at a Glance
4. Multiple System Atrophy Market: Future Perspective
5. Executive Summary of Multiple System Atrophy (MSA)
6. Key Events
7. Disease Background and Overview: Multiple System Atrophy (MSA)
8. Epidemiology and Patient Population
9. Patient Journey
10. Emerging Drugs
11. Multiple System Atrophy (MSA): Seven Major Market Analysis
12. Key Opinion Leaders' View
13. Market Drivers
14. Market Barriers
15. SWOT Analysis
16. Unmet Needs
17. Reimbursement and Market Access
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Consult with our Business Expert regarding "Multiple System Atrophy Market Landscape" @ https://www.delveinsight.com/sample-request/multiple-system-atrophy-msa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Trending Market Reports in 2023
Healthcare Partner Identification Services @ https://www.delveinsight.com/consulting/partner-identification-services
Medical Marijuana Market @ https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Oncolytic Virus Cancer Therapy Pipeline @ https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Overactive Bladder Syndrome Market @ https://www.delveinsight.com/report-store/overactive-bladder-market
Pediatric Growth Hormone Deficiency PGHD Market @ https://www.delveinsight.com/report-store/pediatric-growth-hormone-deficiency-market
Percutaneous Arterial Closure Device Market @ https://www.delveinsight.com/report-store/percutaneous-arterial-closure-device-market
Ranibizumab Biosimilars Insight @ https://www.delveinsight.com/report-store/ranibizumab-biosimilars-insight
Schistosomiasis Market @ https://www.delveinsight.com/report-store/schistosomiasis-market
Stem Cell Market @ https://www.delveinsight.com/report-store/stem-cell-market
Superficial Punctate Keratitis Market @ https://www.delveinsight.com/report-store/superficial-punctate-keratitis-market
Technical Due Diligence @ https://www.delveinsight.com/consulting/due-diligence-services
Transient Ischemic Attack Market @ https://www.delveinsight.com/report-store/transient-ischemic-attack-market
Wilms Tumor Market @ https://www.delveinsight.com/report-store/wilms-tumor-market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash Bhardwaj
info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiple System Atrophy Market Size was approximately USD 125 million in 2022 here
News-ID: 2983832 • Views: …
More Releases from DelveInsight Business Research
Panic Disorder Market Forecast 2032: Rising Global Prevalence and Emerging Thera …
DelveInsight's "Panic Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers a comprehensive evaluation of Panic Disorder, covering historical data, current trends, and future projections across major global markets, including the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
This latest healthcare market forecast offers an extensive assessment of the Panic Disorder landscape, providing detailed insights into revenue patterns, disease prevalence, and evolving treatment approaches. The…
Catheter-related Bloodstream Infection (CRBSI) Pipeline Therapies Analysis 2025: …
DelveInsight's analysis highlights that the Catheter-related Bloodstream Infection (CRBSI) pipeline features over five leading companies actively advancing more than five therapeutic candidates aimed at improving CRBSI management.
DelveInsight's "CRBSI Pipeline Insight 2025" report delivers an in-depth evaluation of ongoing clinical research activities and future growth opportunities within the CRBSI therapeutics landscape.
The Surgical Site Infections Pipeline report offers comprehensive clinical and commercial insights into pipeline candidates ranging from preclinical and discovery stages…
Hepatitis C Virus (HCV) Infection Pipeline Therapies 2025: Over 20 Companies Dri …
According to DelveInsight's evaluation, the global Hepatitis C Virus (HCV) Infection pipeline features more than 20 prominent pharmaceutical and biotechnology companies actively engaged in the development of over 20+ therapeutic candidates. The analysis spans clinical trial activity, therapeutic approaches, mechanisms of action, routes of administration, and recent developments shaping the Hepatitis C Virus Infection treatment landscape.
The "Hepatitis C Virus Infection Pipeline Insight, 2025" report published by DelveInsight delivers an in-depth…
Surgical Site Infections Pipeline Therapies Analysis 2025: Over 5 Companies Driv …
Surgical Site Infections Pipeline Insight 2025: Over 5 Companies Driving Innovation Across 5+ Therapies | DelveInsight
(Albany, United States) According to DelveInsight's analysis, the global Surgical Site Infections pipeline includes more than 5 leading companies actively engaged in the development of over 5 potential SSI therapies. The report provides detailed analysis across clinical trials, therapeutic approaches, mechanisms of action, routes of administration, and recent developmental activities.
DelveInsight's "Surgical Site Infections Pipeline Insight,…
More Releases for Multiple
Mango AI's Multiple Face Swap Video Tool Changes Multiple Faces Instantly
In today's digital world, creating eye-catching and unique content is essential for standing out. The ability to swap multiple faces in a single video opens up creative possibilities, whether for personalized content, comedy or parody videos, or engaging social media posts. Mango AI, developed by Mango Animate, is excited to announce the launch of its advanced multiple face swap video (https://mangoanimate.com/ai/multiple-face-swap-video) tool, which is designed to simplify the creation of…
Multiple Sclerosis Drugs Market
Global Multiple Sclerosis Drugs Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.
Get a Sample Copy of the Report at - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100386
Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as progressive brain and spinal cord atrophy and neuroaxonal…
Massive Multiple Input Multiple Output (MIMO) Market May Set New Growth Story
A Latest intelligence report published by MR Forecast with title "Global Massive Multiple Input Multiple Output (MIMO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Massive Multiple Input Multiple Output (MIMO) market. This report provides a detailed overview of key factors in the Global Massive Multiple Input Multiple Output (MIMO) Market and factors such as driver, restraint, past and current trends,…
Multiple Sclerosis Drugs Market - Progressing Towards a Cure: Advancing Multiple …
Newark, New Castle, USA: The "Multiple Sclerosis Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiple Sclerosis Drugs Market: https://www.growthplusreports.com/report/multiple-sclerosis-drugs-market/7983
This latest report researches the industry structure,…
Multiple Sclerosis Drugs Market - Empowering Resilience, Embracing Possibilities …
Newark, New Castle, USA - new report, titled Multiple Sclerosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Multiple Sclerosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Multiple Sclerosis Drugs market. The report offers an overview of…
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)…
